期刊文献+

光动力疗法治疗息肉状脉络膜血管病变的临床观察 被引量:3

Photodynamic therapy for polypoidal choroidal vasculopathy
下载PDF
导出
摘要 目的:观察光动力疗法(PDT)治疗息肉状脉络膜血管病变(PCV)的治疗效果。方法:临床体征和病史结合荧光素眼底血管造影(FFA)、吲哚氰绿眼底血管造影(ICGA)及相干光断层扫描(OCT)确诊的11例(11只眼)息肉状脉络膜血管病变患者,应用PDT治疗并随访6~30个月,随访期间复查患者最佳矫正视力、眼底,进行FFA,ICGA,OCT检查。结果:PDT治疗后1个月,患者最佳矫正视力:3只眼保持不变,3只眼提高1行,2只眼提高2行,3只眼下降2行。FFA和ICGA检查显示5只眼的血管荧光素渗漏停止,3只眼渗漏减轻,3只眼有轻微渗漏。末次随访时,患者最佳矫正视力:5只眼保持不变,2只眼提高1行,2只眼提高2行,2只眼下降2行。FFA和ICGA检查显示6只眼的血管荧光素渗漏停止,3只眼渗漏减轻,2只眼仍有轻微渗漏。治疗后2个月时有1只眼并发玻璃体积血;未见其他全身及局部不良反应。结论:PDT能使PCV病灶渗漏停止或减轻,促进黄斑区出血、渗出及水肿的吸收,使患者视力稳定或改善,可作为治疗PCV的首选方法之一。 Objective To determine the effect of photodynamic therapy (PDT) for polypoidal choroidal vasculopathy (PCV). Methods Eleven patients (11 eyes) with PCV who were diagnosed by fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA) and optic coherence tomography (OCT) were given PDT. The changes of best corrected visual acuity(BCVA), fundus photography, FFA and ICGA before and after the PDT were compared. Follow-up time varied from 6 to 30 months. Results One month after the PDT, the BCVA was stable in 3eyes, increased in 1 line in 3 eyes, increased in 2 lines in 2 eyes, and decreased in 2 lines in 3 eyes. FFA and ICGA showed no leakage in 5 eyes, leakage reduced in 3 eyes, and slight leakage in 3 eyes. At the last follow-up, the BCVA was stable in 5 eyes, increased in 1 line in 2 eyes, increased in 2 lines in 2 eyes, and decreased in 2 lines in 2 eyes. FFA and ICGA showed no leakage in 6 eyes, leakage reduced in 3 eyes, and slight leakage in 2 eyes. No severe systemic or local ad- verse effect was faired dlirlngor after the PDT aYaont that 1 eye had vltreous hemarrhage 2 months after the PDT. Conclusion PDT may stop or reduce leakage of the lesion, facilitate the absorption of hemorrhage, edema and exudates, and stabilize or increase the patients' visual acuity. It could be a choice for PCV.
作者 游江 郭小健
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2011年第9期899-902,共4页 Journal of Central South University :Medical Science
关键词 脉络膜病变 光化学疗法 维替泊芬 choroid disease photochemotherapy Verteporfin
  • 相关文献

参考文献15

  • 1Tamura H,Tsujikawa A,Otani A,et al.Polypoidal choroidal vasculopathy appearing as classic choroidal neovascularisation on fluorescein angiography[J].Br J Ophthalmol,2007,91(9):1152-1159.
  • 2Nomura Y,Ueta T,Iriyama A,et al.Vitreemacular interface in typical exudative age-related macular degeneration and polypoidal choroidal vasculopathy[J].Ophthalmology,2011,118(5):853-859.
  • 3Gomi F,Tano Y.Polypoidal choroidal vasculopathy and treatments[J].Curr Opin Ophthalnol,2008,19(3):208-212.
  • 4Lee M W,Yeo I,Wong D,et al.Argon laser photocoagulation for the treatment of polypoidal choroidal vasculopathy[J].Eye (Lond),2009,23(1):145-148.
  • 5Yuzawa M,Mori R,Haruyama M.A study of laser photocoagulation for polypoidal choroidal vasculopathy[J].Jpn J Ophthalmol,2003,47 (4):379-384.
  • 6Ciardella A P,Donsoff I M,Yannuzzi L A.Polypoidal choroidal vasculopathy[J].Ophthalmol Clin North Am,2002,15(4):537-554.
  • 7Nishijima K,Takahashi M,Akita J,et al.Laser photocoagulation of indocyanine green angiographically identified feeder vessels to idiopathic polypoidal choroidal vasculopathy[J].Am J Ophthalmol,2004,137 (4):770-773.
  • 8Chang Y C,Wu W C.Polypoidal choroidal vasculopathy in Taiwan Residents patients[J]. Ophthalmic Surg Lasers Imaging,2009,40(6):576-581.
  • 9刘宁朴.重视我国年龄相关性黄斑变性的特征研究[J].中华眼科杂志,2009,45(5):393-395. 被引量:9
  • 10Yarnashita A,Shiraga F,Shiragami C,et al.One-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy[J].Am J Ophthalmol,2010,149(3):465-471.

二级参考文献16

  • 1陈有信,葛坚,严密,金陈进,张美霞,董方田,陆方,张承芬,赵家良.中国维替泊芬光动力疗法治疗年龄相关性黄斑变性中心凹下脉络膜新生血管的多中心临床研究[J].中华眼科杂志,2007,43(3):198-205. 被引量:35
  • 2张风,周海英,熊颖,高丽琴,陈轶.光动力疗法治疗湿性年龄相关性黄斑变性脉络膜新生血管膜的临床效果[J].中华眼科杂志,2007,43(4):350-354. 被引量:11
  • 3Li Y, Xu L, Jonas JB, et al. Prevalence of age-related maculopathy in the adult population in China: the Beijing eye study. Am J Ophthalmol,2006,142:788-793.
  • 4Liu Y, Wen F, Huang S, et al. Subtype lesions of neovascular agerelated macular degeneration in Chinese patients. Graefes Arch Clin Exp Ophthalmol, 2007,245:1441-1445.
  • 5Maruko I, Iida T, Saito M, et al. Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol,2007,144 : 15-22.
  • 6Ciardella AP, Donsoff IM, Huang SJ, et al. Polypoidal choroidal vasculopathy. Surv Ophthalmol,2004,49:25-37.
  • 7Sivaprasad S, Membrey WL, Sivagnanavel V, et al. Second eye of patients with unilateral neovascular age-related macular degeneration : Caucasians vs Chinese. Eye,2006,20:923-926.
  • 8Xu Y,Guan N,Xu J,et al. Association of CFH, LOC387715, and YTRA1 polymorphisms with exudative age-related macular degeneration in a northern Chinese population. Mol Vis ,2008,14: 1373-1381.
  • 9Chen LJ, Liu DT,Tam PO, et al. Association of complement factor H polymorphisms with exudative age-related macular degeneration. Mol Vis, 2006,12 : 1536-1542.
  • 10Lau LI, Chen SJ, Cheng CY, et al. Association of the Y402H polymorphism in complement factor H gene and neovascular agerelated macular degeneration in Chinese patients. Invest Ophthalmol Vis Sci ,2006,47:3242-3246.

共引文献8

同被引文献28

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部